Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
European Heart Journal Open
|
March 31, 2025
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programme
Doralisa Morrone, Leon Dinshaw, José Antonio Gordillo de Souza, et al.
JACC. Advances
|
February 26, 2026
Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making: ENGAGE AF-TIMI 48 Trial Analysis
C Michael Gibson, Cathy Chen, Jacqueline Buros-Novik, et al.
Journal of Endourology
|
September 11, 2003
Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function
David I Lee, Cassio R Andreoni, Jamil Rehman, et al.
American Heart Journal
|
January 6, 2022
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups
Baris Gencer, Alon Eisen, David Berger, et al.
Journal of the American Heart Association
|
May 15, 2025
Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE-TAVI AF Trial
George D Dangas, Martin Unverdorben, Johny Nicolas, et al.
American Heart Journal
|
September 2, 2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial
Nicolas M Van Mieghem, Martin Unverdorben, Marco Valgimigli, et al.
Neuro-Oncology Advances
|
September 15, 2022
An investigation of the conformity, feasibility, and expected clinical benefits of multiparametric MRI-guided dose painting radiotherapy in glioblastoma
Caterina Brighi, Paul J Keall, Lois C Holloway, et al.
Molecular Medicine (Cambridge, Mass.)
|
July 26, 2016
Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate
Noriko Satake, Connie Duong, Sakiko Yoshida, et al.
Physics and Imaging in Radiation Oncology
|
June 23, 2022
Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration
Caterina Brighi, Niels Verburg, Eng-Siew Koh, et al.
The American Journal of Cardiology
|
September 23, 2023
Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation
Masanori Yamamoto, Kentaro Hayashida, Christian Hengstenberg, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
European Heart Journal Open
|
March 31, 2025
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programme
Doralisa Morrone, Leon Dinshaw, José Antonio Gordillo de Souza, et al.
JACC. Advances
|
February 26, 2026
Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making: ENGAGE AF-TIMI 48 Trial Analysis
C Michael Gibson, Cathy Chen, Jacqueline Buros-Novik, et al.
Journal of Endourology
|
September 11, 2003
Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function
David I Lee, Cassio R Andreoni, Jamil Rehman, et al.
American Heart Journal
|
January 6, 2022
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups
Baris Gencer, Alon Eisen, David Berger, et al.
Journal of the American Heart Association
|
May 15, 2025
Comparing Major Gastrointestinal Bleeding in Patients Receiving Edoxaban Versus Warfarin After Transcatheter Aortic Valve Replacement: Results From the Randomized ENVISAGE-TAVI AF Trial
George D Dangas, Martin Unverdorben, Johny Nicolas, et al.
American Heart Journal
|
September 2, 2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial
Nicolas M Van Mieghem, Martin Unverdorben, Marco Valgimigli, et al.
Neuro-Oncology Advances
|
September 15, 2022
An investigation of the conformity, feasibility, and expected clinical benefits of multiparametric MRI-guided dose painting radiotherapy in glioblastoma
Caterina Brighi, Paul J Keall, Lois C Holloway, et al.
Molecular Medicine (Cambridge, Mass.)
|
July 26, 2016
Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate
Noriko Satake, Connie Duong, Sakiko Yoshida, et al.
Physics and Imaging in Radiation Oncology
|
June 23, 2022
Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration
Caterina Brighi, Niels Verburg, Eng-Siew Koh, et al.
The American Journal of Cardiology
|
September 23, 2023
Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation
Masanori Yamamoto, Kentaro Hayashida, Christian Hengstenberg, et al.
Page
of 7